Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 10/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.55 |
| ▸ | TP53 | P04637 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6688047 | 0.90 | HCAR3 (0.77) | HCAR3MAPTRXFP1TP53 | |
| SCHEMBL12380480 | 0.78 | HCAR3 (0.73) | HCAR3MAPTLMNATSHR | |
| SCHEMBL6044076 | 0.76 | HCAR3 (1.00) | HCAR3MAPTRXFP1TP53ALDH1A1 | |
| SCHEMBL27273144 | 0.75 | HCAR3 (0.78) | HCAR3MAPTRXFP1TP53ALDH1A1 | |
| SCHEMBL6044131 | 0.75 | HCAR3 (1.00) | HCAR3MAPTRXFP1TP53 | |
| SCHEMBL6044508 | 0.73 | HCAR3 (1.00) | HCAR3 | |
| SCHEMBL6044013 | 0.72 | HCAR3 (1.00) | HCAR3MAPTRXFP1TP53 | |
| SCHEMBL13153983 | 0.70 | HCAR3 (0.60) | HCAR3MAPTRXFP1TP53LMNA | |
| SCHEMBL6043957 | 0.70 | HCAR3 (1.00) | HCAR3MAPTRXFP1TP53 | |
| SCHEMBL13153979 | 0.69 | HCAR3 (0.57) | HCAR3MAPTRXFP1TP53ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004041274-A1 | BENZOTRIAZOLES AND METHODS OF PROPHYLAXIS OR TREATMENT OF METABOLIC-RELATED DISORDERS THEREOF | ARENA PHARMACEUTICALS, INC. (US) | 2004-05-21 | — | — | WO | claimed |